200 Million Dollars to Engineer the Next Generation of Military Working Dogs

The United States military faces a stark logistical challenge: more than 80% of its working dogs are sourced from Europe, and fewer than half of those imported animals are ultimately fit for service. This dwindling domestic supply has left the nation increasingly reliant on foreign nations for animals that play critical roles in bomb detection, search operations, and other hazardous tasks. To address this gap, Warhound has emerged from stealth mode, backed by $200 million in funding to develop genetically engineered canines specifically designed for demanding defense and law enforcement missions.

The venture was born from a collaboration between Ben Lamm of Colossal Biosciences and Palmer Luckey of Anduril. Lamm noted that he met Luckey at a conference roughly a year ago, where the topic of military canine welfare was discussed. Following that introduction, Lamm researched the breeding practices of current working dogs, discovering that many fail training due to inherited predispositions to issues such as poor eyesight, cancer, hip dysplasia, or muscle atrophy. This research laid the groundwork for a company that values at $1.2 billion after securing investment from Sequoia, 8VC, Corner Ventures, and In-Q-Tel, a venture firm supported by U.S. intelligence agencies.

Warhound’s approach combines biological enhancement with technological support. The team has established a biobank using cell lines from top-performing breeds, including Belgian Malinois and German Shepherds. By editing these genes, the company intends to add traits that improve speed, agility, and olfactory sensitivity while removing genetic markers associated with health problems. The goal is to create a new type of dog that is healthier, longer-lived, and better suited for the rigors of fieldwork.

While Colossal handles the genetic engineering, Anduril will provide the hardware and software to support these animals. This includes protective vests equipped with data sensors and goggles designed to improve situational awareness for both the dogs and their handlers. Lamm described the technology as an external layer that makes the dogs safer and more effective, noting that it enhances performance beyond what genetics alone can achieve. Luckey serves as a partner in the venture but holds no equity, while Colossal retains ownership and licenses its technology to the new entity.

The timeline for these enhanced canines is ambitious. The first batch of dogs is currently being cloned and incubated by Viagen, a Colossal-owned company with a high cloning success rate. Births are expected in early 2027, with the animals ideally entering service within two years. The company has not yet determined pricing but plans to sell to first responders, the Department of Defense, police forces, and other military service groups. Lamm confirmed that the company has already briefed numerous government bodies on the business model.

Addressing concerns about civilian safety and animal welfare, Lamm stated that each dog will undergo standard military working dog training and be managed by its purchaser. To further ensure ethical treatment, Warhound is working under the guidance of the American Humane Society to certify its training program. The Society, which described itself as grounded in science and ethics, applauded the inclusion of the organization in the process. It also noted that retired dogs could potentially enter its Military Working Dog Reunification Program, which provides homes for veterans of the canine corps.

As Colossal Biosciences expands beyond its known de-extinction efforts, such as reviving the dodo and mammoth, Warhound represents a significant pivot toward practical application. By leveraging AI and gene cloning technologies previously used to protect endangered species, the company aims to reduce the physical toll on military dogs and, by extension, their human handlers. The project highlights a growing trend in defense technology where biological and digital enhancements are converging to meet specific operational needs.